verified SJR 1,304 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Drug Discovery lock_open Open Access

Current Opinion in Pharmacology

Current Opinion in Pharmacology is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 153. It has an SJR impact factor of 1,304 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,304.

Current Opinion in Pharmacology focuses its scope in these topics and keywords: cardiovascular, therapeutic, cancer, lung, cell, hormones, critically, augmented, facilitates, antiinfectives, ...

ISSN: 1471-4892

Publisher: Elsevier Ltd

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,304 Q1

H-index 153

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,304

H-index

153

Docs (year)

Docs 3y

300

Total refs

2156

Cites 3y

1211

Citable 3y

283

Cites/Doc 2y

4.12

Ref/Doc

61.6

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cancer Immunomodulation

Using genetic variation to study immunomodulation

Drug transport via the intestinal peptide transporter PepT1

Drug inhibition of angiogenesis

Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development

Cyclooxygenase-2 and inflammation in atherosclerosis

Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs

Cotransmission

Conductances responsible for slow wave generation and propagation in interstitial cells of Cajal

Clinical uses and misuses of dehydroepiandrosterone

Changes and challenges - the world post-Gleevec‚Ñ¢ (Glivec¬Æ)

CFTR pharmacology and its role in intestinal fluid secretion

SHOW MORE ARTICLES

Cellular screening assays using fluorescence microscopy

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer

Calcium channels in enteric neurons

beta-Lactamase-inhibitor combinations in the 21st century: current agents and new developments

Applications of microarrays in the pharmaceutical industry

Anti-inflammatory therapy for heart failure

Anti-infectives: New technologies

Anti-infectives New technologies

Anti-infectives

Anti-infective challenges in the 21st century: from superbugs to viral pandemics

Adult growth hormone replacement: current understanding

Acid-sensitive ion channels in gastrointestinal function

FAQs

Current Opinion in Pharmacology has an SJR of 1,304 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Opinion in Pharmacology is 22%.

Current Opinion in Pharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Opinion in Pharmacology?

What is the APC / publication cost?

What is the acceptance rate?